B. N. Prashanth Kumar

The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer

P. Venkatesan, Nagaprasad Puvvada, Rupesh Dash et al. · Biomaterials · 2011 · 255 citations

Nanomedicine, Engineering, Polymer-drug Conjugate +8

Synthesis of biocompatible multicolor luminescent carbon dots for bioimaging applications

Nagaprasad Puvvada, B. N. Prashanth Kumar, Suraj Konar et al. · Science and Technology of Advanced Materials · 2012 · 182 citations · Full text

Nanoparticles, Nanomedicine, Chemical Engineering +14

Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells

Shashi Rajput, B. N. Prashanth Kumar, Kaushik Dey et al. · Life Sciences · 2013 · 140 citations

Chemoprevention Strategy, Translation Inhibition, Apoptosis +10

Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer

Goutam Dey, Rashmi Bharti, Gunaseelan Dhanarajan et al. · Scientific Reports · 2015 · 126 citations · Full text

Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer

Shashi Rajput, B. N. Prashanth Kumar, Siddik Sarkar et al. · PLoS ONE · 2013 · 117 citations · Full text

Breast Oncology, Chemoprevention Strategy, Apoptosis Protein +16